Webinars and Presentations

Foundation Fighting Blindness and Odylia Therapeutics Pre-clinical and Translational Webinar Series

WEBINAR #1: Tools for Preclinical Development: Creating a Target Product Profile and Effectively Engaging Regulatory Entities (October 2020)

WEBINAR #2: Disease relevant translation models in ocular drug development: Types, challenges, advantages, and alternatives (November 17th, 2020)

WEBINAR #3: Working with Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) to accelerate development (January 2021)

WEBINAR #4: Attracting funding opportunities and a look towards the future of ocular drug development (February 2021)

Recent Conference Presentations

The challenges of bringing gene therapy treatments for rare disease to clinical trial, World Orphan Drug Congress Europe 2020, Scott Dorfman, CEO

Exploring Innovative Partnerships to Enable Gene Therapy Manufacturing for Rare Ocular Disorders, Gene Therapy for Ophthalmic Disorders 2020- Ashley Winslow, CSO

PANEL DISCUSSION: Evaluating the Current Commercial Landscape in Light of a Recent Ophthalmic Approval, Gene Therapy for Ophthalmic Disorders 2020- Ashley Winslow, CSO

Sharing Insight for Gene Therapy Manufacturing, The NIH and FDA Workshop on Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies, Scott Dorfman, CEO